Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Sanofi ( (SNY) ) has issued an announcement.

Berger specialized in cancer long before joining Genentech, holding oncology global clinical development roles at Amgen and ...

French drug major Sanofi (SNY) announced Friday that the U.S. Food and Drug Administration has granted Breakthrough Therapy ...

Attorney Aaron Siri is an ally of HHS sectretary nominee Robert F. Kennedy Jr. He asked the FDA to withdraw or suspend the ...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of ...

(Reuters) -Gilead Sciences said on Thursday it has appointed Sanofi’s Dietmar Berger as its chief medical officer, replacing ...

Aaron Siri - a lawyer with a history of seeking to expand exemptions to vaccines- asked the FDA to suspend or withdraw ...

Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...

The company announced it achieved the first milestone under its Sanofi partnership, earning a $50 million payment for ...

A lawyer working with Robert F. Kennedy Jr. has asked the F.D.A. to withdraw approval of the current shot because it hasn’t ...

Gilead Sciences, Inc. has announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical ...